GlassScriptPhysician profile
Andrea Taylor
NPI 1629415781
$4,977.88
in general payments reported to CMS, 2019-2025
24 companies · $708 in 2025
The $708 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $531 · 2020: $1,015 · 2021: $672 · 2022: $563 · 2023: $710 · 2024: $778 · 2025: $708.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,989 · Education: $207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,988.99 |
| Education | $207.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,005.48 | 2019-2025 | Rinvoq, Skyrizi, Botox |
| Regeneron Healthcare Solutions, INC. | $635.48 | 2019-2025 | Dupixent |
| Galderma Laboratories, L.P. | $563.04 | 2019-2024 | Dysport |
| Genzyme Corporation | $403.40 | 2019-2025 | |
| Amgen INC. | $399.28 | 2019-2025 | Otezla, Otezla |
| Lilly USA, LLC | $319.54 | 2019-2025 | Ebglyss |
| Pfizer INC. | $268.25 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $206.02 | 2019-2025 | Blu-U |
| Novartis Pharmaceuticals Corporation | $190.75 | 2019-2025 | |
| Janssen Biotech, INC. | $161.57 | 2019-2025 | Tremfya, Simponi Aria, Simponi |
| E.R. Squibb & Sons, L.L.C. | $118.61 | 2024-2025 | Sotyktu |
| Incyte Corporation | $109.83 | 2022-2024 | Opzelura |
| Dermira, INC. | $109.03 | 2019-2021 | |
| Ucb, INC. | $107.07 | 2020-2021 | |
| Leo Pharma INC. | $101.75 | 2021-2023 | Adbry |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $99.99 | 2020 | |
| Merz North America, INC. | $30.49 | 2024 | |
| Allergan, INC. | $28.66 | 2021-2022 | |
| Strata Skin Sciences, INC. | $23.41 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.35 | 2025 | Spevigo |
| Sanofi Pasteur INC. | $20.68 | 2024 | |
| Dusa Pharmaceuticals, INC. | $19.01 | 2019 | |
| Almirall LLC | $18.66 | 2019 | |
| Mayne Pharma Commercial LLC | $15.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.